February 12, 2021
Participants in the CABANA trial who had stable heart failure mostly with preserved ejection fraction in addition to atrial fibrillation (AF) at baseline fared better when they underwent catheter ablation than when they were started on medical therapy alone, a detailed subgroup analysis shows.
Those randomized to ablation had lower risks of mortality, the primary composite outcome of the trial (death, disabling stroke, serious bleeding, or cardiac arrest), and AF recurrence, as well as improved quality of life, according to researchers led by Douglas Packer, MD (Mayo Clinic Hospital St. Marys Campus, Rochester, MN), principal investigator for the trial.
CNN s Laura Jarrett is answering your questions as minorities face hurdles to vaccination
CNN s Go There is in New York as minorities face hurdles to vaccination.
For example, last month, a Covid-19 vaccination site in a Latino neighborhood in New York City hard hit by the pandemic saw an overwhelming number of White people from outside the community show up to get the shot this month, laying bare a national disparity that shows people of color are being vaccinated at dramatically lower rates.
Laura Jarrett is answering your questions.
Watch more:
12:07 p.m. ET, February 11, 2021
FC Bayern Munich star Thomas Müller to miss FIFA Club World Cup Final after positive Covid-19 test
Modelling an important factor in COVID-19 public-health decisions The use of data is vital in making the best and most informed decision in the public-health world. And while health units in Ontario are subject to the province’s decisions, the modelling used at the more local level has helped guide recommendations and resources as COVID-19 cases both increase and decline.
Author of the article: Greg Colgan
Publishing date: Feb 12, 2021 • February 13, 2021 • 3 minute read • This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange, emerging from the surface of cells, green, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. The sample was isolated from a patient in the U.S. Photo by SUPPLIED /The Canadian Press
Modelling an important factor in COVID-19 public health decisions The use of data is vital in making the best and most informed decision in the public-health world. And while health units in Ontario are subject to the province’s decisions, the modelling used at the more local level has helped guide recommendations and resources as COVID-19 cases both increase and decline.
Author of the article: Greg Colgan
Publishing date: Feb 12, 2021 • February 13, 2021 • 3 minute read • This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange, emerging from the surface of cells, green, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. The sample was isolated from a patient in the U.S. Photo by SUPPLIED /The Canadian Press
President Joe Biden is uniquely placed to deliver the People s Vaccine and convert the lessons of the crisis to build a new, transformative economy centered on the shared prosperity of humankind.